A Novel Microfluidic Platform for Organoid Culture and Drug Screening

By

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

By

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

A Novel Microfluidic Platform for Organoid Culture and Drug Screening

A microfluidic PDAC-on-a-chip model co-culturing organoids with stromal cells to mimic tumor hypoxia and stroma—supporting high-throughput drug screening and patient-specific therapy development for pancreatic cancer.

By